Related Experiment Videos
[Experimental characterization of propafenone. Hemodynamic effects].
Giornale Italiano Di Cardiologia
|May 1, 1984
Summary
Propafenone, an antiarrhythmic drug, shows minimal cardiac depression effects when administered intravenously. This study indicates its safety, even in patients with mild heart failure.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Assessing the cardiovascular impact of antiarrhythmic drugs is crucial for patient safety.
- Propafenone is a widely used Class Ic antiarrhythmic agent.
Purpose:
- To evaluate the acute hemodynamic effects of intravenous Propafenone administration.
- To determine the safety profile of Propafenone in patients with abnormal baseline hemodynamics or mild heart failure.
Summary:
- Twenty subjects underwent coronary arteriography and left ventriculography for hemodynamic assessment.
- Propafenone was administered intravenously at 1 mg/kg over 5 minutes, with measurements taken at baseline, 10, and 20 minutes.
- Results indicated a very small depression of cardiac inotropism, even in subjects with abnormal baseline hemodynamics.
Impact:
- Intravenous Propafenone demonstrates a favorable safety profile with minimal cardiac depression.
- The findings support the safe use of Propafenone in patients with mild heart failure.